On the stock market since 1980, it operates in the world of technology. It has 230,025 employees. Now — the numbers.
This is an established company with proven profits.
The biggest line carries real weight, but it doesn’t decide everything on its own.
No real growth (3% a year).
The gap is $507B. In times of high interest rates, a gap like that can squeeze a company.
The stock trades 34% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 8% a year on average.
It pays out $0.23 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, PCRFY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: PCRFY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.